Skip to main content
Home
FULL MENU Close Menu
Home
Home

Neil Osterweil

News

Made-to-order TILs effective against metastatic melanoma

Author:
Neil Osterweil
Publish date: April 22, 2022

The product, called lifileucel, is custom made for each patient.

  • Read More

News

‘Major advance’: Sotorasib benefit persists in KRAS+ NSCLC

Author:
Neil Osterweil
Publish date: April 22, 2022

The finding comes from an analysis of long-term follow-up data from the CodeBreaK100 trial.

  • Read More

News

Sex differences in COPD slow to be recognized, treated

Author:
Neil Osterweil
Publish date: April 12, 2022

Science and society have been slow to catch on to sex-based differences in clinical presentation and response to...

  • Read More

News

Global melanoma incidence high and on the rise

Author:
Neil Osterweil
Publish date: April 5, 2022

The highest incidence and mortality rates of cutaneous melanoma are in wealthy nations, a new study shows.

  • Read More

News

Adverse skin effects of cancer immunotherapy reviewed

Author:
Neil Osterweil
Publish date: March 21, 2022

“The desirable, immune-mediated oncologic response is often achieved at the cost of immune-related adverse events (irAEs) that may potentially...

  • Read More

News

Gene therapy for hemophilia A: `Truly transformative and liberating’

Author:
Neil Osterweil
Publish date: March 17, 2022

This first-generation gene therapy offers a new choice for care that could be 'truly transformative and liberating' for eligible men with...

  • Read More

News

CPAP has only small effect on metabolic syndrome

Author:
Neil Osterweil
Publish date: March 15, 2022

Although the benefit was small, CPAP was more effective than nasal strips at reversing the metabolic syndrome in...

  • Read More

News

Rare pediatric cancers persist 63 years after nuclear accident

Author:
Neil Osterweil
Publish date: March 15, 2022

Near Los Angeles, the parents of kids whose cluster of rare leukemias and other cancers may be linked to a 1959 partial meltdown at Santa Susana...

  • Read More

News

New gene signals for asthma-COPD overlap identified

Author:
Neil Osterweil
Publish date: March 4, 2022

A genome-wide association study of individuals with asthma-COPD overlap identified genetic variants that could...

  • Read More

News

High early recurrence rates with Merkel cell carcinoma

Author:
Neil Osterweil
Publish date: March 3, 2022

Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.

  • Read More

News

New hemophilia treatments: ‘Our cup runneth over’

Author:
Neil Osterweil
Publish date: February 15, 2022

A range of new options is emerging to treat hemophilia patients.

  • Read More

News

Handle with care: Managing IBD in older patients

Author:
Neil Osterweil
Publish date: February 15, 2022

Patients 60 and older with chronic or newly diagnosed IBD may have comorbidities or use medications that can interfere with IBD therapies.

  • Read More

News

Malnutrition common in patients with IBD

Author:
Neil Osterweil
Publish date: February 14, 2022

As many as 85% of patients hospitalized with IBD may be malnourished, dietary experts cautioned.

  • Read More

News

Breakthrough COVID-19 milder in vaccinated patients with IBD

Author:
Neil Osterweil
Publish date: February 14, 2022

Patients with inflammatory bowel disease who are vaccinated but still develop COVID experience milder disease than those who are unvaccinated.

  • Read More

News

Cystic fibrosis in retreat, but still unbeaten

Author:
Neil Osterweil
Publish date: February 9, 2022

Improvements in care and novel therapies have dramatically increased life expectancy and improved quality of...

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close